Oral solid dosage forms remain the dominant delivery approach for most pharmaceuticals, because of their convenience, good patient compliance, and low manufacturing costs. This technical article provides insights on trends shaping the evolving manufacturing landscape for solid dosage forms, including advances in excipients and the impact on formulation development and manufacturing processes.